Breaking News
Sort by:
Top Post
Taysha Gene Therapies Announces First Patient Dosed with TSHA-102 in the REVEAL Phase 1/2 Trial for the Treatment of Rett Syndrome
Taysha Gene Therapies, a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene […]
VITRAC Therapeutics Initiates a Phase 1 Clinical Trial for the Treatment of Non-Small Cell Lung Cancer
VITRAC Therapeutics initiated a Phase 1 Study of VIC-1911 as monotherapy and in combination with […]
Memo Therapeutics AG Announces Positive Phase I Data with AntiBKV for Treatment of BKV Infection
Memo Therapeutics AG, an innovator in the field of antibody discovery and development, announced today […]
OxSonics Announces First-in-human Clinical Data Shows SonoTran(R) is Safe and Well-tolerated
OxSonics Therapeutics, a clinical-stage medtech company focused on transforming cancer treatment through SonoTran, its proprietary […]
Priothera Announces First Patients Enrolled in Pivotal Global Study for Patients with Acute Myeloid Leukemia
Priothera, a late-clinical stage biotechnology company pioneering the development of its S1P receptor modulator compound […]
First Patient Dosed in CANbridge Pharmaceuticals Trial for the Treatment of Gaucher Disease in China
CANbridge Pharmaceuticals, a global biopharmaceutical company, with a foundation in China, committed to the research, […]
Avacta Announces Successful Completion of Fourth Dose Escalation in AVA6000 Phase 1 Clinical Study
Avacta Group, a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics announces […]
EverImmune launches Phase I Clinical Trial for its Oncobiotic Drug Candidate in Lung and Kidney Cancer
EverImmune, a clinical-stage biotechnology company specialized in the development of live biotherapeutic products in the […]
CNS Pharmaceuticals Announces Investigator-Initiated Phase 1b/2 Trial to be Conducted at the Pomeranian Medical University in Poland
CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and […]
Autolomous to Provide Digital Solutions to Center for Breakthrough Medicines to Streamline and Automate Manufacturing of Cell & Gene Therapies
Autolomous LTD, the market-leading developer of critical manufacturing management systems for Cell and Gene Therapies (CGT), has announced […]
Oramed Announces Top-line Results from Phase 3 Trial of ORMD-0801 for the Treatment of Type 2 Diabetes
Oramed Pharmaceuticals, a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more